Patienter med allerede eksisterende leverdysfunktion, inklusive kronisk, aktiv hepatitis, har en øget forekomst af abnorm leverfunktion under antiretroviral kombinationsbehandling og bør monitoreres i overensstemmelse med standardpraksis.
Patients with pre-existing liver dysfunction, including chronic active hepatitis, have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.